These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18473401)
1. Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma. Ishikawa T World J Gastroenterol; 2008 May; 14(18):2797-801. PubMed ID: 18473401 [TBL] [Abstract][Full Text] [Related]
2. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. Ishikawa T; Ichida T; Sugitani S; Tsuboi Y; Genda T; Sugahara S; Uehara K; Inayoshi J; Yokoyama J; Ishimoto Y; Asakura H J Gastroenterol Hepatol; 2001 Apr; 16(4):452-9. PubMed ID: 11354285 [TBL] [Abstract][Full Text] [Related]
3. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil. Ishikawa T; Ichida T; Ishimoto Y; Yokoyama J; Nomoto M; Ebe Y; Usuda H; Naito M; Asakura H Am J Gastroenterol; 1999 Jun; 94(6):1682-5. PubMed ID: 10364045 [TBL] [Abstract][Full Text] [Related]
4. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study. Ishikawa T; Imai M; Kamimura H; Tsuchiya A; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T World J Gastroenterol; 2007 Nov; 13(41):5465-70. PubMed ID: 17907289 [TBL] [Abstract][Full Text] [Related]
5. A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients. Une Y; Kamiyama T; Nishibe M; Shimamura T; Haneda T; Nakanishi K; Uchino J Anticancer Drugs; 1996 Nov; 7(8):881-4. PubMed ID: 8991193 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Ikeda K; Saitoh S; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H Am J Clin Oncol; 1995 Jun; 18(3):204-10. PubMed ID: 7747707 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma. Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398 [TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. Hsu CY; Shen YC; Yu CW; Hsu C; Hu FC; Hsu CH; Chen BB; Wei SY; Cheng AL; Shih TT J Hepatol; 2011 Oct; 55(4):858-65. PubMed ID: 21338641 [TBL] [Abstract][Full Text] [Related]
9. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages. Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group. Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511 [TBL] [Abstract][Full Text] [Related]
11. Low-dose cisplatin plus oral tegafur and uracil for the treatment of lung metastases of hepatocellular carcinoma. Maeda T; Itasaka H; Takenaka K; Matsumata T; Shimada M; Ikeda T; Sugimachi K Hepatogastroenterology; 2003; 50(53):1583-6. PubMed ID: 14571791 [TBL] [Abstract][Full Text] [Related]
12. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases]. Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190 [TBL] [Abstract][Full Text] [Related]
13. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. Miyamoto A; Umeshita K; Sakon M; Nagano H; Eguchi H; Kishimoto S; Dono K; Nakamori S; Gotoh M; Monden M J Gastroenterol Hepatol; 2000 Dec; 15(12):1447-51. PubMed ID: 11197059 [TBL] [Abstract][Full Text] [Related]
14. [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil]. Miyano M; Kurai O; Hiramatsu S; Yamasaki T; Sasaki E; Adachi K; Oka H Gan To Kagaku Ryoho; 2010 Jun; 37(6):1139-43. PubMed ID: 20567124 [TBL] [Abstract][Full Text] [Related]
15. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma. Rubiales AS; del Valle ML Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583 [No Abstract] [Full Text] [Related]
16. [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. Tanabe K; Taura K; Hatano E; Koyama Y; Takada Y; Uemoto S Gan To Kagaku Ryoho; 2013 Aug; 40(8):1077-80. PubMed ID: 23986055 [TBL] [Abstract][Full Text] [Related]
17. Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer. Kanaji N; Bandoh S; Ishida T South Med J; 2007 Oct; 100(10):1056-7. PubMed ID: 17943058 [No Abstract] [Full Text] [Related]
18. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. Hsu CH; Shen YC; Lin ZZ; Chen PJ; Shao YY; Ding YH; Hsu C; Cheng AL J Hepatol; 2010 Jul; 53(1):126-31. PubMed ID: 20416968 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system. Takahashi Y; Yamashita K; Endo Y; Sasaki T; Mai M Surg Today; 2004; 34(10):855-9. PubMed ID: 15449156 [TBL] [Abstract][Full Text] [Related]
20. [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function]. Ikeda K; Kumada H; Arase Y; Nakamura I; Chayama K; Murashima N; Takeuchi K; Nakajima M; Yoshiba A; Irimoto M Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2377-85. PubMed ID: 2830421 [No Abstract] [Full Text] [Related] [Next] [New Search]